Compare Stocks → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AQXPNASDAQ:CHMANASDAQ:GRTXNYSE:MNKNASDAQ:NEPT Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAQXPAquinox Pharmaceuticals$29.87-1.2%$3.94$2.00▼$3.84$703.14M-7.37239,362 shs71,109 shsCHMAChiasma$3.76$4.01$2.77▼$5.74$217.68M1.282.12 million shs147 shsGRTXGalera Therapeutics$0.21+10.7%$0.20$0.09▼$3.59$11.29M2.172.35 million shs662,154 shsMNKMallinckrodt$0.12$0.34$0.75▼$6.42$1.58MN/A2.62 million shs39,227 shsNEPTNeptune Wellness Solutions$0.39$0.19▼$28.00$906K2.19462,687 shs2.25 million shs7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAQXPAquinox Pharmaceuticals-4.17%-11.21%-39.60%-6.66%+3,435.33%CHMAChiasma0.00%0.00%0.00%0.00%0.00%GRTXGalera Therapeutics+13.57%+11.56%+12.77%+16.90%-92.50%MNKMallinckrodt0.00%0.00%0.00%0.00%-97.89%NEPTNeptune Wellness Solutions0.00%0.00%0.00%-55.36%-99.22%“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars).MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAQXPAquinox PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ACHMAChiasmaN/AN/AN/AN/AN/AN/AN/AN/AGRTXGalera TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AMNKMallinckrodtN/AN/AN/AN/AN/AN/AN/AN/ANEPTNeptune Wellness SolutionsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAQXPAquinox PharmaceuticalsN/AN/AN/AN/ACHMAChiasmaN/AN/AN/AN/AGRTXGalera Therapeutics1.75ReduceN/AN/AMNKMallinckrodtN/AN/AN/AN/ANEPTNeptune Wellness SolutionsN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAQXPAquinox Pharmaceuticals$25M28.13N/AN/A$3.09 per share9.67CHMAChiasma$1.11M196.11N/AN/A$1.59 per share2.36GRTXGalera TherapeuticsN/AN/AN/AN/A($2.41) per shareN/AMNKMallinckrodtN/AN/AN/AN/A$47.48 per shareN/ANEPTNeptune Wellness Solutions$52.62M0.00N/AN/A($91.90) per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAQXPAquinox Pharmaceuticals-$31.58MN/A0.00∞N/AN/A-30.13%-28.08%N/ACHMAChiasma-$74.78M-$1.43N/AN/AN/AN/A-113.57%-57.62%N/AGRTXGalera Therapeutics-$59.08M-$1.41N/A∞N/AN/AN/A-137.47%5/9/2024 (Estimated)MNKMallinckrodtN/A-$116.19N/A∞N/A-82.59%20.32%2.49%N/ANEPTNeptune Wellness Solutions-$60.46M-$106.72N/AN/AN/A-128.13%N/A-141.94%7/15/2024 (Estimated)Latest AQXP, CHMA, GRTX, MNK, and NEPT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/28/2024Q4 2023GRTXGalera TherapeuticsN/A-$0.10-$0.10-$0.10N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAQXPAquinox PharmaceuticalsN/AN/AN/AN/AN/ACHMAChiasmaN/AN/AN/AN/AN/AGRTXGalera TherapeuticsN/AN/AN/AN/AN/AMNKMallinckrodtN/AN/AN/AN/AN/ANEPTNeptune Wellness SolutionsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAQXPAquinox PharmaceuticalsN/A63.1763.17CHMAChiasmaN/A7.917.08GRTXGalera TherapeuticsN/A4.364.36MNKMallinckrodt1.180.570.31NEPTNeptune Wellness SolutionsN/A0.230.10OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAQXPAquinox Pharmaceuticals71.69%CHMAChiasma61.68%GRTXGalera Therapeutics50.77%MNKMallinckrodt83.74%NEPTNeptune Wellness Solutions14.44%Insider OwnershipCompanyInsider OwnershipAQXPAquinox Pharmaceuticals4.00%CHMAChiasma8.30%GRTXGalera Therapeutics6.90%MNKMallinckrodt0.30%NEPTNeptune Wellness Solutions5.10%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAQXPAquinox Pharmaceuticals823.54 millionN/ANot OptionableCHMAChiasma8557.89 millionN/ANot OptionableGRTXGalera Therapeutics754.39 million50.64 millionOptionableMNKMallinckrodt2,70013.17 million13.13 millionNot OptionableNEPTNeptune Wellness Solutions584.53 million4.30 millionNot OptionableAQXP, CHMA, GRTX, MNK, and NEPT HeadlinesSourceHeadlineNeptune Wellness Solutions (NASDAQ:NEPT) Now Covered by Analysts at StockNews.comamericanbankingnews.com - April 16 at 2:22 AMNeptune prepared to take legal action against property owner of the homeless encampmentmsn.com - April 9 at 2:18 PMCity of Neptune Beach unveils new water tower designmsn.com - April 7 at 1:48 PMGunbattle between Haitian police and gangs paralyzes area near National Palacesaratogian.com - April 2 at 1:45 AMThe Wellness Innovation Summit at the Knoxville Convention Center Saturday, April 6thwate.com - April 1 at 10:44 AMSNAPSHOT: Construction supervisor credits BOCES with building him a solid foundation for his futuresaratogian.com - April 1 at 10:44 AMWellness Wednesday – Focusing on Cardiovascular Healthnwahomepage.com - March 28 at 6:30 PMFood Encapsulation Market Industry Chain Information, Emerging Market Regions (2024-2032)taiwannews.com.tw - March 28 at 6:30 PMSNAPSHOT: The Bunker celebrates opening of newest location in Saratoga Springssaratogian.com - March 25 at 8:40 AMSNAPSHOT: Capital Region BOCES event will link students to employers and recruiterssaratogian.com - March 24 at 9:05 AMKingdom Wellness & Dispensary opens new retail locationwestsidenewsny.com - March 18 at 12:39 PMWellness expo promotes better health within Black familiesksdk.com - March 17 at 8:17 PMRooted Wellness celebrates grand openinglowellsun.com - March 15 at 8:16 PMClinton to host Mayor's Wellness Program on Saturday, March 23newjerseyhills.com - March 15 at 3:15 PMYour Weekly Horoscopes: March 17 to 23, 2024purewow.com - March 15 at 12:13 AMHealthwise Wellness hosts clinic open housearkansasonline.com - March 13 at 7:38 AMSouthwell Center for Healing and Wellness to permanently closemsn.com - March 12 at 12:26 AMNeptune Software: 'Environmental Supply Chains - You Don't Need to Sacrifice Profitability to Act Sustainably'tmcnet.com - March 11 at 2:25 PMNeptune Wellness Solutions Inc.wsj.com - March 9 at 8:59 AMNeptune Wellness appoints Michael De Geus as interim president, CEOmsn.com - March 8 at 9:40 AMNeptune Appoints Interim President and CEO and Interim COOaccesswire.com - March 8 at 8:30 AMNeptune Wellness to be delisted from Nasdaqinvesting.com - March 8 at 12:42 AMTop Marijuana Stocks For Trading Today 2024marijuanastocks.com - March 6 at 9:06 AMNeptune Announces Decision of Nasdaq Hearings Panel To Delist Common Sharesaccesswire.com - March 6 at 8:30 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAquinox PharmaceuticalsNASDAQ:AQXPAquinox Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in developing novel therapeutics for chronic urological conditions by inflammation and pain. The company focuses on a library of novel compounds that activate SH2-containing inositol-5'-phosphatase 1 (SHIP1) to develop therapeutics for application in inflammation, inflammatory pain, and blood cancers. Its lead product candidate is Rosiptor (Leadership 301), a small molecule activator of SHIP1 that is in Phase III clinical trials for treatment in interstitial cystitis/bladder pain syndrome. The company was formerly known as Aquinox Pharmaceuticals (USA) Inc. and changed its name to Aquinox Pharmaceuticals, Inc. in January 2014. Aquinox Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Vancouver, Canada.ChiasmaNASDAQ:CHMAChiasma, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company offers MYCAPSSA, an oral octreotide capsule for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. It also develops MPOWERED, an oral octreotide capsule, which has completed Phase III clinical trials for the maintenance treatment of adult patients with acromegaly. Chiasma, Inc. was incorporated in 2001 and is headquartered in Needham, Massachusetts.Galera TherapeuticsNASDAQ:GRTXGalera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also developing GC4711, a dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.MallinckrodtNYSE:MNKMallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.Neptune Wellness SolutionsNASDAQ:NEPTNeptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.